US 6642227
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
expired A61PA61P1/00A61P1/04
Quick answer
US patent 6642227 (Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18